ONCOMAL ApS: Financial statements 2022
CVR: 34580367
ONCOMAL ApS (CVR 34580367) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -229,703 and a net result of DKK -639,153 compared with DKK -628,272 the year before. Equity amounted to DKK 101,699,540. The solvency ratio was 87.9%.
- Gross Profit
- -229,703 kr.
- Profit/Loss
- -639,153 kr.
- Equity
- 101,699,540 kr.
- Total Assets
- 115,686,343 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -230 t. | -639 t. | 101.7 mio. | - |
| 2021 | - | -321 t. | -628 t. | 65.1 mio. | - |
| 2020 | - | -39 t. | -216 t. | 65.8 mio. | - |
| 2019 | - | -35 t. | -201 t. | 66 mio. | - |
| 2018 | - | -344 t. | -445 t. | 66.2 mio. | - |
Keep an eye on ONCOMAL ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ONCOMAL ApS has published its annual report for 2021. Gross profit came to DKK -320,739, and the net result was DKK -628,272.
As of April 1, 2022, Josef Rainer has joined the board of directors of ONCOMAL ApS.
About ONCOMAL ApS
ONCOMAL ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Thor Grundtvig Theander, Ali El-Salanti and Mads Daugaard. The company's owners include Thor Grundtvig Theander, Ali El-Salanti and Mads Daugaard. In 2025, the company reported a gross profit of DKK -515,532 and a net result of DKK -1,882,091 compared with DKK -1,216,243 the year before. Equity amounted to DKK 232,154,411.
